Anthem will further evaluate Aduhelm before it announces whether or not the Alzheimer's drug will be covered, Yahoo News reported.
The news came July 21 during the insurer's second-quarter earnings call.
Anthem joins UnitedHealth in waiting to cover the drug since its FDA approval, while a handful of Blue Cross Blue Shield affiliates have declined to cover it.